Cell and Gene CDMO Services
SK pharmteco provides specialized solutions for Cell and Gene Therapy, encompassing viral vector manufacturing, plasmid DNA production, analytical testing, and...
SK pharmteco and AaviGen Announce Strategic Partnership to Manufacture AaviGen’s Lead Gene Therapy Product for Heart Failure
FOR IMMEDIATE RELEASE PARIS, France and HEIDELBERG, Germany (October 2, 2024) – SK pharmteco, a global contract development and manufacturing...
SK pharmteco and Rznomics Explore Collaboration for RNA-based Gene Therapy Development and Manufacturing
SEONGNAM, South Korea, Aug. 5, 2024 – SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving both...
How CAR T Manufacturing is Revolutionizing Cancer Treatment
Chimeric antigen receptor T-cell (CAR T) therapy has emerged as a groundbreaking approach to cancer treatment, particularly for patients with...
Artificial Intelligence: Your Guide to Crossing the CGT Cost Chasm
Explore strategies and solutions to navigate the CGT cost landscape effectively.
Getting More Gene and Cell Therapy Treatments To Patients
Getting More Gene and Cell Therapy Treatments To Patients
A Right-First-Time Approach to Development
By Tatiana Nanda, Director and Program Leader and Brian Tomkowicz, Sr. Director, Vector Engineering & Manufacturability, Center for…